Cellectar Biosciences, Inc. (CLRB) vs IN8bio, Inc. (INAB)
- Cellectar Biosciences, Inc. CLRB 1.14 −4.20%
- IN8bio, Inc. INAB 1.11 −6.72%
Cellectar Biosciences, Inc. and IN8bio, Inc. are both Biotechnology companies. Cellectar Biosciences, Inc. and IN8bio, Inc. are of similar size ($11.7M and $11.2M). Across the 9 metrics below, Cellectar Biosciences, Inc. leads on 5 and IN8bio, Inc. on 4.
Valuation
Profitability
| Metric | CLRB | INAB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (125.99%) | (111.11%) | (56.36%) |
| Return on assets | (88.70%) | (90.80%) | (48.04%) |
| Return on invested capital | 0.00% | (2,948.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack